Loading clinical trials...
Loading clinical trials...
An Observational Study of the Real Life Management of the Psoriasis Patients Treated With Enbrel According to the New Reimbursement Criteria - Beflex Study
With the new reimbursement criteria, we want: To describe the average treatment duration of patients with Enbrel expressed as a number of weeks/year. To describe the number of patients who receive continuous treatment To describe the number of patients who receive intermittent treatment To describe the number of weeks off treatment
100 patients will be followed for at least 1 year
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Herestraat 49
Leuven, Belgium
Start Date
September 1, 2011
Primary Completion Date
June 1, 2013
Completion Date
June 1, 2013
Last Updated
June 30, 2014
140
ACTUAL participants
Enbrel treatment
OTHER
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions